[HTML][HTML] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology–a prospective study

SR Chaminda, T Suchintha, NM Anuk, DA Supun… - BMC …, 2017 - Springer
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study.

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - europepmc.org
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study.

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - search.ebscohost.com
Abstract < bold> Background: </bold> Alpha-fetoprotein (AFP) is a biomarker for
hepatocellular carcinoma (HCC). The significance of pre-treatment AFP (pt-AFP) in non-viral …

[PDF][PDF] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study

SR Chaminda, T Suchintha, NM Anuk, DA Supun - 2017 - researchgate.net
Abstract Background: Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma
(HCC). The significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not …

[HTML][HTML] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology–a prospective study

SR Chaminda, T Suchintha… - BMC …, 2017 - bmcgastroenterol.biomedcentral …
Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The significance
of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Patients with nvHCC …

[HTML][HTML] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology–a prospective study

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - ncbi.nlm.nih.gov
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - go.gale.com
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study.

SR Chaminda, T Suchintha, NM Anuk… - BMC …, 2017 - europepmc.org
Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

[PDF][PDF] Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology-a prospective study

SR Chaminda, T Suchintha, NM Anuk… - 2017 - bmcgastroenterol.biomedcentral …
Abstract Background: Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma
(HCC). The significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not …